On Thursday, December 17, 2019, the Food and Drug Administration approved a vaccine made by Merck for the Zaire strain of the Ebola virus, which caused more than 11,000 deaths during the 2014 West Africa outbreak and has caused more than 2,000 deaths in the current outbreak in the eastern Democratic Republic of the Congo.Full Release
MedicalCountermeasures.gov can help you keep up-to-date on the latest developments in federal medical countermeasures activities, with information on public meetings and conferences, procurement and grant opportunities, strategies, reports, federal guidance on the development of medical countermeasures, and other announcements.
Provides links to information about public meetings, both upcoming and past, on issues pertaining to public health threats, both naturally occurring and manmade. Also included are links to online Meeting Libraries, such as the NIH Videocasting site.Learn More
Procurements and Grants
Provides links to relevant federal guidance on issues related to the development medical countermeasures, including information on Emergency Use Authorization, the Animal Efficacy Rule, and the Select Agent Rule.
Federal Business Opportunities (FedBizOpps) is the single government point-of-entry (GPE) for Federal government procurement opportunities over $25,000. Commercial vendors seeking Federal markets for their products and services can search, monitor and retrieve opportunities solicited by the entire Federal contracting community through FedBizOpps.Learn More
Provides links to relevant federal guidance on issues related to the development medical countermeasures, including information on Emergency Use Authorization, the Animal Efficacy Rule, and the Select Agent Rule.Learn More
Strategies and Reports
Provides links to sources of information useful to those involved in the research, development, and acquisition of medical countermeasures products, including Project Bioshield, and Public Health Emergency Medical Countermeasures Enterprise.Learn More
The Federal Government has launched several major initiatives intended to accelerate basic research and development of vaccines, therapeutics, and diagnostics for naturally occurring and manmade threats.Learn More
Latest news releases related to medical countermeasures
OPPORTUNITIES TO PARTNER WITH BARDA
Today, the U.S. Department of Health and Human Services (HHS) issued the first Project BioShield contract to fund the advanced development needed to support the expanded use of an existing antibiotic to treat exposure to inhalational anthrax.Full Release
The U.S. Department of Health and Human Services (HHS) issued a six-year, $226 million contract today to increase capacity to produce recombinant influenza vaccine in the United States. The contract is in accordance with the Sept. 19 presidential executive order to enhance national security...Full Release